PHYTURE BIOTECH

About Phyture Biotech, SL

Created in 2009 as a spin-off of the Pharmacy Faculty of the University of Barcelona, Phyture Biotech bases all of its activities in its technological platform of vegetable cell culture. With this technology one can modify the metabolism of the cells to obtain innovative extracts of high added value and that are more efficient and safe than the traditional ones. Phyture Biotech is a pioneer in the application of this technology in the industry.
On the one hand a new range of products is being developed based on the culture of unique vegetal cells. These products will then become active ingredients destined to the cosmetic, dermatologic and pharmaceutical industry.
On the other hand, researches are being carried out to optimize the technology in the production of recombinant proteins. Even thought currently they are not commonly used, the vegetable cells have a great potential in this sector because of their unique characteristics.

Investment in Phyture Biotech S.L

In the BioSpain congress in 2012 an agreement of investment was presented by the Knowledge capital fund for the company Phyture Biotech S,L, becoming the first company where the fund invested. InKemia entered this biotechnological company with an investment of 270.000 € participating with 21,26% in its capital

ENEMCE PHARMA

About Enemce Pharma, S.L:

Enemce Pharma is a classic Drug Discovery company created with the objective of developing a new candidate for medicines for preventing cardiovascular diseases.

Ivestment in Enemce Pharma

In November 2012, the knowledge capital fund makes a second round of investments in the company Enemce Pharma, with an initial contribution of 5.500 €., in the beginning of 2014 a second contribution of another 5.400 €. was made.
These contributions have as an objective the development of a first stage of proof of concept, in case this is successful new stages and investments would be develop.

BIODAN SCIENCES S.L.

About Biodan Sciences, SL

Created in 2011 this company has as objective to supply the most advanced natural ingredients, through liberation mechanisms that are more efficient than the ones provided by the ingredients obtained by traditional chemistry.
For this, Bioadan applies the latest advances in the field of immunology and the applied biotechnology to active ingredients extracted from plants. The founding values for the generation of these innovative products are: the use of very advanced technologies, the search for a greater efficiency, and the use of safe natural products that are produced and developed in an ethical way.

Investment in Biodan Sciences, S.L.

In November 2013 InKemia enters the company Bioadan Sciences with an investment of 240.000 €. This contribution gave InKemia a share of 19% of Biodan’s capital with the possibility of becoming a 21% in the next years.

PLASMIA BIOTECH

MIND THE BYTE

LEAN BIO